292 related articles for article (PubMed ID: 36324258)
1. N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3.
Shi HZ; Xiong JS; Gan L; Zhang Y; Zhang CC; Kong YQ; Miao QJ; Tian CC; Li R; Liu JQ; Zhang EJ; Bu WB; Wang Y; Cheng XF; Sun JF; Chen H
Clin Transl Med; 2022 Nov; 12(11):e1075. PubMed ID: 36324258
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways.
Xiao K; Liu P; Yan P; Liu Y; Song L; Liu Y; Xie L
Bioengineered; 2022 May; 13(5):11973-11986. PubMed ID: 34709120
[TBL] [Abstract][Full Text] [Related]
3. YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in Oxaliplatin-Resistant Colorectal Cancer.
Zhao Y; Zhao H; Zhang D; Quan Q; Ge Y; Li L; Guo L
ACS Chem Biol; 2022 Jul; 17(7):1778-1788. PubMed ID: 35708211
[TBL] [Abstract][Full Text] [Related]
4. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
5. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
6. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
7. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p.
Hu Y; Tang J; Xu F; Chen J; Zeng Z; Han S; Wang F; Wang D; Huang M; Zhao Y; Huang Y; Zhuo W; Zhao G
J Exp Clin Cancer Res; 2022 Feb; 41(1):69. PubMed ID: 35183226
[TBL] [Abstract][Full Text] [Related]
8. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
9. Synchronous profiling of mRNA N6-methyladenosine modifications and mRNA expression in high-grade serous ovarian cancer: a pilot study.
Yang L; Liu J; Jin Y; Xing J; Zhang J; Chen X; Yu A
Sci Rep; 2024 May; 14(1):10427. PubMed ID: 38714753
[TBL] [Abstract][Full Text] [Related]
10. HIV protease cleaves the antiviral m6A reader protein YTHDF3 in the viral particle.
Jurczyszak D; Zhang W; Terry SN; Kehrer T; Bermúdez González MC; McGregor E; Mulder LCF; Eckwahl MJ; Pan T; Simon V
PLoS Pathog; 2020 Feb; 16(2):e1008305. PubMed ID: 32053707
[TBL] [Abstract][Full Text] [Related]
11. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract][Full Text] [Related]
12. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of FTO inhibits excessive proliferation and promotes the apoptosis of human glomerular mesangial cells by alleviating FOXO6 m6A modification via YTHDF3-dependent mechanisms.
Zhuang X; Liu T; Wei L; Gao J
Front Pharmacol; 2023; 14():1260300. PubMed ID: 37822879
[No Abstract] [Full Text] [Related]
14. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
[TBL] [Abstract][Full Text] [Related]
16. METTL3-mediated m
Feng ZW; Peng B; Wang SH; Zhao DC; Wang YB; Yang A; Zhan HW; Sheng XY; Xu LH; Ren XJ; Yang F; Geng B; Xia YY
Cell Signal; 2024 Mar; 115():111038. PubMed ID: 38195035
[TBL] [Abstract][Full Text] [Related]
17. m
Lobo J; Costa AL; Cantante M; Guimarães R; Lopes P; Antunes L; Braga I; Oliveira J; Pelizzola M; Henrique R; Jerónimo C
J Transl Med; 2019 Mar; 17(1):79. PubMed ID: 30866959
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance.
Yu R; Yu Q; Li Z; Li J; Yang J; Hu Y; Zheng N; Li X; Song Y; Li J; Chen X; Du W; Su J
Clin Epigenetics; 2023 Dec; 15(1):194. PubMed ID: 38098098
[TBL] [Abstract][Full Text] [Related]
19. YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m
Lin Y; Jin X; Nie Q; Chen M; Guo W; Chen L; Li Y; Chen X; Zhang W; Chen H; Jiang M; Xiao H; Zhang J; Fu F; Wang C
Ann Transl Med; 2022 Jan; 10(2):83. PubMed ID: 35282088
[TBL] [Abstract][Full Text] [Related]
20. EGR2-mediated regulation of m
Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
